Hosted on MSN
Seer reiterates $17M–$18M revenue target for 2025 amid macro headwinds and new Proteograph ONE launch
Omid C. Farokhzad, Founder, CEO & Chair of the Board, stated Q2 2025 was a pivotal quarter with "discipline, advance key commercial and product milestones and accelerate the validation and impact of ...
Good day, and welcome to the Seer, Inc. Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results